Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma

February 7, 2024

Abstract

Dogs with B-cell lymphoma typically respond well to first-line CHOP-based chemotherapy, but there is no standard of care for relapsed patients. To help veterinary oncologists select effective drugs for dogs with lymphoid malignancies such as B-cell lymphoma, we have developed multimodal machine learning models that integrate data from multiple tumor profiling modalities and predict the likelihood of a positive clinical response for 10 commonly used chemotherapy drugs. Here we report on clinical outcomes that occurred after oncologists received a prediction report generated by our models. Remarkably, we found that dogs that received drugs predicted to be effective by the models experienced better clinical outcomes by every metric we analyzed (overall response rate, complete response rate, duration of complete response, patient survival times) relative to other dogs in the study and relative to historical controls.

Read the full article here: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1304144/full

Scientific Publications

Identification of novel genetic mutations for the treatment prognostication of canine lymphoma

npj Precision Oncology
Learn More →

A study on the relationship between MDR1 mutation and ex vivo drug sensitivities of canine lymphomas

Biotechnology and Bioprocess Engineering
Learn More →

Recent advances in and applications of ex vivo drug sensitivity analysis for blood cancers

Blood Research
Learn More →

Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas

Veterinary Sciences
Learn More →

Prognostic value of European LeukemiaNet 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia

Haematologica
Learn More →

ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

npj Precision Oncology
Learn More →

Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model

Veterinary Sciences
Learn More →

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary and Comparative Oncology
Learn More →